Reversible cutaneous lymphoma occurring during methotrexate therapy
Identifieur interne : 002281 ( Istex/Corpus ); précédent : 002280; suivant : 002282Reversible cutaneous lymphoma occurring during methotrexate therapy
Auteurs : R. Viraben ; P. Brousse ; L. LamantSource :
- British Journal of Dermatology [ 0007-0963 ] ; 1996-07.
Abstract
Summary A B‐cell lymphoma, restricted to the skin, developed in a 58‐year‐old man receiving methotrexate for non‐rheumatoid peripheral arthritis, with the simultaneous occurrence of a cytolytic hepatitis and carcinoma of the lung. Two weeks after methotrexate was stopped, both the skin tumour and the hepatitis disappeared spontaneously, with no recurrence during a 12‐month follow‐up period. Immunoglobulin gene rearrangement was shown by polymerase chain reaction (PCR) but in situ hybridization failed to reveal neoplastic cells positive for Epstein‐Barr virus (EBV).
Url:
DOI: 10.1046/j.1365-2133.1996.d01-946.x
Links to Exploration step
ISTEX:BEE4962ABED858B5E2F9093D925804377F78D4E9Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reversible cutaneous lymphoma occurring during methotrexate therapy</title><author><name sortKey="Viraben, R" sort="Viraben, R" uniqKey="Viraben R" first="R." last="Viraben">R. Viraben</name><affiliation><mods:affiliation>Department of Dermatology, Purpan and La Grave Hospital, Toulouse, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence address: Dr R. Viraben, Service de Dermatologie, Hopital La Grave, Place Lange, 31052 Toulouse Cedex, France.</mods:affiliation></affiliation></author><author><name sortKey="Brousse, P" sort="Brousse, P" uniqKey="Brousse P" first="P." last="Brousse">P. Brousse</name><affiliation><mods:affiliation>Department of Pathology, Purpan and La Grave Hospital, Toulouse, France</mods:affiliation></affiliation></author><author><name sortKey="Lamant, L" sort="Lamant, L" uniqKey="Lamant L" first="L." last="Lamant">L. Lamant</name><affiliation><mods:affiliation>Department of Pathology, Purpan and La Grave Hospital, Toulouse, France</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BEE4962ABED858B5E2F9093D925804377F78D4E9</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1046/j.1365-2133.1996.d01-946.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-1ZZMB2RV-C/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002281</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002281</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Reversible cutaneous lymphoma occurring during methotrexate therapy</title><author><name sortKey="Viraben, R" sort="Viraben, R" uniqKey="Viraben R" first="R." last="Viraben">R. Viraben</name><affiliation><mods:affiliation>Department of Dermatology, Purpan and La Grave Hospital, Toulouse, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence address: Dr R. Viraben, Service de Dermatologie, Hopital La Grave, Place Lange, 31052 Toulouse Cedex, France.</mods:affiliation></affiliation></author><author><name sortKey="Brousse, P" sort="Brousse, P" uniqKey="Brousse P" first="P." last="Brousse">P. Brousse</name><affiliation><mods:affiliation>Department of Pathology, Purpan and La Grave Hospital, Toulouse, France</mods:affiliation></affiliation></author><author><name sortKey="Lamant, L" sort="Lamant, L" uniqKey="Lamant L" first="L." last="Lamant">L. Lamant</name><affiliation><mods:affiliation>Department of Pathology, Purpan and La Grave Hospital, Toulouse, France</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">British Journal of Dermatology</title><title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title><idno type="ISSN">0007-0963</idno><idno type="eISSN">1365-2133</idno><imprint><biblScope unit="vol">135</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="116">116</biblScope><biblScope unit="page" to="118">118</biblScope><biblScope unit="page-count">3</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1996-07">1996-07</date></imprint><idno type="ISSN">0007-0963</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0007-0963</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Summary A B‐cell lymphoma, restricted to the skin, developed in a 58‐year‐old man receiving methotrexate for non‐rheumatoid peripheral arthritis, with the simultaneous occurrence of a cytolytic hepatitis and carcinoma of the lung. Two weeks after methotrexate was stopped, both the skin tumour and the hepatitis disappeared spontaneously, with no recurrence during a 12‐month follow‐up period. Immunoglobulin gene rearrangement was shown by polymerase chain reaction (PCR) but in situ hybridization failed to reveal neoplastic cells positive for Epstein‐Barr virus (EBV).</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>methotrexate</json:string><json:string>cutaneous</json:string><json:string>rheumatoid</json:string><json:string>rheumatoid arthritis</json:string><json:string>lymphoma</json:string><json:string>methotrexate therapy</json:string><json:string>lymphoproliferative</json:string><json:string>rearrangement</json:string><json:string>primer</json:string><json:string>phenotype</json:string><json:string>tumour</json:string><json:string>immunoglobulin</json:string><json:string>dermatomyositis</json:string><json:string>british association</json:string><json:string>arthritis</json:string><json:string>gene rearrangement</json:string><json:string>skin biopsy</json:string><json:string>organ transplantation</json:string><json:string>immunoglobulin gene rearrangement</json:string><json:string>polymerase chain reaction</json:string><json:string>nodal lymphoma</json:string><json:string>bronchogenic carcinoma</json:string><json:string>viral infection</json:string><json:string>lymphoproliferative disorder</json:string><json:string>lymphoproliferative process</json:string></teeft></keywords><author><json:item><name>R. VIRABEN</name><affiliations><json:string>Department of Dermatology, Purpan and La Grave Hospital, Toulouse, France</json:string><json:string>Correspondence address: Dr R. Viraben, Service de Dermatologie, Hopital La Grave, Place Lange, 31052 Toulouse Cedex, France.</json:string></affiliations></json:item><json:item><name>P. BROUSSE</name><affiliations><json:string>Department of Pathology, Purpan and La Grave Hospital, Toulouse, France</json:string></affiliations></json:item><json:item><name>L. LAMANT</name><affiliations><json:string>Department of Pathology, Purpan and La Grave Hospital, Toulouse, France</json:string></affiliations></json:item></author><articleId><json:string>BJD116</json:string></articleId><arkIstex>ark:/67375/WNG-1ZZMB2RV-C</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>caseStudy</json:string></originalGenre><abstract>Summary A B‐cell lymphoma, restricted to the skin, developed in a 58‐year‐old man receiving methotrexate for non‐rheumatoid peripheral arthritis, with the simultaneous occurrence of a cytolytic hepatitis and carcinoma of the lung. Two weeks after methotrexate was stopped, both the skin tumour and the hepatitis disappeared spontaneously, with no recurrence during a 12‐month follow‐up period. Immunoglobulin gene rearrangement was shown by polymerase chain reaction (PCR) but in situ hybridization failed to reveal neoplastic cells positive for Epstein‐Barr virus (EBV).</abstract><qualityIndicators><score>4.289</score><pdfWordCount>1341</pdfWordCount><pdfCharCount>8940</pdfCharCount><pdfVersion>1.6</pdfVersion><pdfPageCount>4</pdfPageCount><pdfPageSize>573 x 789 pts</pdfPageSize><pdfWordsPerPage>335</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>79</abstractWordCount><abstractCharCount>571</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Reversible cutaneous lymphoma occurring during methotrexate therapy</title><pmid><json:string>8776373</json:string></pmid><genre><json:string>case-report</json:string></genre><host><title>British Journal of Dermatology</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1365-2133</json:string></doi><issn><json:string>0007-0963</json:string></issn><eissn><json:string>1365-2133</json:string></eissn><publisherId><json:string>BJD</json:string></publisherId><volume>135</volume><issue>1</issue><pages><first>116</first><last>118</last><total>3</total></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>1996</json:string></date><geogName></geogName><orgName></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName></persName><placeName></placeName><ref_url></ref_url><ref_bibl></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-1ZZMB2RV-C</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - dermatology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - dermatology & venereal diseases</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Dermatology</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>1996</publicationDate><copyrightDate>1996</copyrightDate><doi><json:string>10.1046/j.1365-2133.1996.d01-946.x</json:string></doi><id>BEE4962ABED858B5E2F9093D925804377F78D4E9</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-1ZZMB2RV-C/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-1ZZMB2RV-C/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-1ZZMB2RV-C/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Reversible cutaneous lymphoma occurring during methotrexate therapy</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1996-07"></date></publicationStmt><notesStmt><note type="content-type" subtype="case-report" source="caseStudy" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-29919SZJ-6">case-report</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="case-report"><analytic><title level="a" type="main">Reversible cutaneous lymphoma occurring during methotrexate therapy</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">R.</forename><surname>VIRABEN</surname></persName><affiliation><orgName type="department">Department of Dermatology</orgName><orgName type="institution">Purpan and La Grave Hospital</orgName><address><addrLine>Toulouse</addrLine><addrLine>France</addrLine><country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">P.</forename><surname>BROUSSE</surname></persName><affiliation><orgName type="department">Department of Pathology</orgName><orgName type="institution">Purpan and La Grave Hospital</orgName><address><addrLine>Toulouse</addrLine><addrLine>France</addrLine><country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">L.</forename><surname>LAMANT</surname></persName><affiliation><orgName type="department">Department of Pathology</orgName><orgName type="institution">Purpan and La Grave Hospital</orgName><address><addrLine>Toulouse</addrLine><addrLine>France</addrLine><country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><idno type="istex">BEE4962ABED858B5E2F9093D925804377F78D4E9</idno><idno type="ark">ark:/67375/WNG-1ZZMB2RV-C</idno><idno type="DOI">10.1046/j.1365-2133.1996.d01-946.x</idno><idno type="unit">BJD116</idno><idno type="toTypesetVersion">file:BJD.BJD116.pdf</idno></analytic><monogr><title level="j" type="main">British Journal of Dermatology</title><title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title><idno type="pISSN">0007-0963</idno><idno type="eISSN">1365-2133</idno><idno type="book-DOI">10.1111/(ISSN)1365-2133</idno><idno type="book-part-DOI">10.1111/bjd.1996.135.issue-1</idno><idno type="product">BJD</idno><idno type="publisherDivision">ST</idno><imprint><biblScope unit="vol">135</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="116">116</biblScope><biblScope unit="page" to="118">118</biblScope><biblScope unit="page-count">3</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1996-07"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en" style="main"><p><hi rend="bold">Summary
</hi> A B‐cell lymphoma, restricted to the skin, developed in a 58‐year‐old man receiving methotrexate for non‐rheumatoid peripheral arthritis, with the simultaneous occurrence of a cytolytic hepatitis and carcinoma of the lung. Two weeks after methotrexate was stopped, both the skin tumour and the hepatitis disappeared spontaneously, with no recurrence during a 12‐month follow‐up period. Immunoglobulin gene rearrangement was shown by polymerase chain reaction (PCR) but <hi rend="italic">in situ</hi> hybridization failed to reveal neoplastic cells positive for Epstein‐Barr virus (EBV).</p></abstract><textClass><keywords rend="tocHeading1"><term>Case reports</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-1ZZMB2RV-C/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1365-2133</doi><issn type="print">0007-0963</issn><issn type="electronic">1365-2133</issn><idGroup><id type="product" value="BJD"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="BRITISH JOURNAL OF DERMATOLOGY">British Journal of Dermatology</title></titleGroup></publicationMeta><publicationMeta level="part" position="07001"><doi origin="wiley">10.1111/bjd.1996.135.issue-1</doi><numberingGroup><numbering type="journalVolume" number="135">135</numbering><numbering type="journalIssue" number="1">1</numbering></numberingGroup><coverDate startDate="1996-07">July 1996</coverDate></publicationMeta><publicationMeta level="unit" type="caseStudy" position="0011600" status="forIssue"><doi origin="wiley">10.1046/j.1365-2133.1996.d01-946.x</doi><idGroup><id type="unit" value="BJD116"></id></idGroup><countGroup><count type="pageTotal" number="3"></count></countGroup><titleGroup><title type="tocHeading1">Case reports</title></titleGroup><eventGroup><event type="firstOnline" date="2008-06-28"></event><event type="publishedOnlineFinalForm" date="2008-06-28"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-08"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-15"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-15"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="116">116</numbering><numbering type="pageLast" number="118">118</numbering></numberingGroup><correspondenceTo>Dr R. Viraben, Service de Dermatologie, Hopital La Grave, Place Lange, 31052 Toulouse Cedex, France.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:BJD.BJD116.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Accepted for publication 13 September 1995</unparsedEditorialHistory><countGroup><count type="referenceTotal" number="12"></count><count type="linksCrossRef" number="4"></count></countGroup><titleGroup><title type="main">Reversible cutaneous lymphoma occurring during methotrexate therapy</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" corresponding="yes"><personName><givenNames>R.</givenNames><familyName>VIRABEN</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a2"><personName><givenNames>P.</givenNames><familyName>BROUSSE</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a2"><personName><givenNames>L.</givenNames><familyName>LAMANT</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="FR"><unparsedAffiliation>Department of Dermatology, Purpan and La Grave Hospital, Toulouse, France</unparsedAffiliation></affiliation><affiliation xml:id="a2" countryCode="FR"><unparsedAffiliation>Department of Pathology, Purpan and La Grave Hospital, Toulouse, France</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><p><b>Summary
</b> A B‐cell lymphoma, restricted to the skin, developed in a 58‐year‐old man receiving methotrexate for non‐rheumatoid peripheral arthritis, with the simultaneous occurrence of a cytolytic hepatitis and carcinoma of the lung. Two weeks after methotrexate was stopped, both the skin tumour and the hepatitis disappeared spontaneously, with no recurrence during a 12‐month follow‐up period. Immunoglobulin gene rearrangement was shown by polymerase chain reaction (PCR) but <i>in situ</i> hybridization failed to reveal neoplastic cells positive for Epstein‐Barr virus (EBV).</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Reversible cutaneous lymphoma occurring during methotrexate therapy</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Reversible cutaneous lymphoma occurring during methotrexate therapy</title></titleInfo><name type="personal"><namePart type="given">R.</namePart><namePart type="family">VIRABEN</namePart><affiliation>Department of Dermatology, Purpan and La Grave Hospital, Toulouse, France</affiliation><affiliation>Correspondence address: Dr R. Viraben, Service de Dermatologie, Hopital La Grave, Place Lange, 31052 Toulouse Cedex, France.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">BROUSSE</namePart><affiliation>Department of Pathology, Purpan and La Grave Hospital, Toulouse, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">LAMANT</namePart><affiliation>Department of Pathology, Purpan and La Grave Hospital, Toulouse, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="case-report" displayLabel="caseStudy" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-29919SZJ-6">case-report</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">1996-07</dateIssued><edition>Accepted for publication 13 September 1995</edition><copyrightDate encoding="w3cdtf">1996</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="references">12</extent><extent unit="linksCrossRef">4</extent></physicalDescription><abstract lang="en">Summary A B‐cell lymphoma, restricted to the skin, developed in a 58‐year‐old man receiving methotrexate for non‐rheumatoid peripheral arthritis, with the simultaneous occurrence of a cytolytic hepatitis and carcinoma of the lung. Two weeks after methotrexate was stopped, both the skin tumour and the hepatitis disappeared spontaneously, with no recurrence during a 12‐month follow‐up period. Immunoglobulin gene rearrangement was shown by polymerase chain reaction (PCR) but in situ hybridization failed to reveal neoplastic cells positive for Epstein‐Barr virus (EBV).</abstract><relatedItem type="host"><titleInfo><title>British Journal of Dermatology</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><identifier type="ISSN">0007-0963</identifier><identifier type="eISSN">1365-2133</identifier><identifier type="DOI">10.1111/(ISSN)1365-2133</identifier><identifier type="PublisherID">BJD</identifier><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>135</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>116</start><end>118</end><total>3</total></extent></part></relatedItem><relatedItem type="references" displayLabel="cit1"><titleInfo><title>Reversibility of lymphoma and lymphoproliferative lesions developing under cyclosporinsteroid therapy</title></titleInfo><name type="personal"><namePart type="given">TE</namePart><namePart type="family">Starzi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Nalesnik</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KA</namePart><namePart type="family">Porter</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Starzi TE. Nalesnik MA. Porter KA. et al. Reversibility of lymphoma and lymphoproliferative lesions developing under cyclosporinsteroid therapy. Lancet 1984; i: 583 – 7.</note><part><date>1984</date><detail type="volume"><caption>vol.</caption><number>i</number></detail><extent unit="pages"><start>583</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>1984</date><detail type="volume"><caption>vol.</caption><number>i</number></detail><extent unit="pages"><start>583</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit2"><titleInfo><title>Brief report: Reversible lymphomas associated with Epstein‐Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis</title></titleInfo><name type="personal"><namePart type="given">OW</namePart><namePart type="family">Kamel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">van de Rijn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LM</namePart><namePart type="family">Weiss</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kamel OW. van de Rijn M, Weiss, LM et al. Brief report: Reversible lymphomas associated with Epstein‐Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993; 328: 1317 – 21.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>328</number></detail><extent unit="pages"><start>1317</start><end>21</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>328</number></detail><extent unit="pages"><start>1317</start><end>21</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit3"><titleInfo><title>Reversible lymphomas</title></titleInfo><name type="personal"><namePart type="given">JB</namePart><namePart type="family">Shiroky</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MM</namePart><namePart type="family">Newkirk</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shiroky JB. Newkirk MM. Reversible lymphomas. N Engl J Med 1993; 329: 1657 – 8.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>329</number></detail><extent unit="pages"><start>1657</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>329</number></detail><extent unit="pages"><start>1657</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit4"><titleInfo><title>Gene rearrangement in B and T‐lymphoproliferative disease detected by the polymerase chain reaction</title></titleInfo><name type="personal"><namePart type="given">KJ</namePart><namePart type="family">Trainor</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Brisco</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JH</namePart><namePart type="family">Wan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Trainor KJ. Brisco MJ. Wan JH. et al. Gene rearrangement in B and T‐lymphoproliferative disease detected by the polymerase chain reaction. Blood 1991; 78: 192 – 6.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>78</number></detail><extent unit="pages"><start>192</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>78</number></detail><extent unit="pages"><start>192</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit5"><titleInfo><title>Regressing cutaneous lymphomas of T‐cell and B‐cell lineage</title></titleInfo><name type="personal"><namePart type="given">JE</namePart><namePart type="family">Holder</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PS</namePart><namePart type="family">Collogy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Fletcher</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PE</namePart><namePart type="family">Hutchinson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Holder JE, Collogy PS, Fletcher A, Hutchinson PE. Regressing cutaneous lymphomas of T‐cell and B‐cell lineage. Br J Dermatol 1995; 132: 815 – 20.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>815</start><end>20</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>815</start><end>20</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit6"><titleInfo><title>Auftreten eines hochmalignen Non‐Hodgkin‐Lymphoms im Zusammenhang mit einer Imurek‐Therapie und spater MTX‐Therapie bei chronischer Polyarthritis</title></titleInfo><name type="personal"><namePart type="given">HP</namePart><namePart type="family">Klein</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Klein HP. Auftreten eines hochmalignen Non‐Hodgkin‐Lymphoms im Zusammenhang mit einer Imurek‐Therapie und spater MTX‐Therapie bei chronischer Polyarthritis. Z. Rheumatol 1992; 51: 256 – 9.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>51</number></detail><extent unit="pages"><start>256</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>Z. Rheumatol</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>51</number></detail><extent unit="pages"><start>256</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit7"><titleInfo><title>Artritis reumatoide y neoplasia multiple</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Ivorra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Massuti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Roman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ivorra J. Massuti B. Roman J. et al. Artritis reumatoide y neoplasia multiple. Med Clin (Barc) 1991; 97: 383 – 5.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>97</number></detail><extent unit="pages"><start>383</start><end>5</end></extent></part><relatedItem type="host"><titleInfo><title>Med Clin (Barc)</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>97</number></detail><extent unit="pages"><start>383</start><end>5</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit8"><titleInfo><title>Non Hodkin's lymphoma, rheumatoid arthritis and methotrexate</title></titleInfo><name type="personal"><namePart type="given">JC</namePart><namePart type="family">Cobeta‐Garcia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MT</namePart><namePart type="family">Ruiz‐Jimeno</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Fontova‐Garrofe</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cobeta‐Garcia JC, Ruiz‐Jimeno MT, Fontova‐Garrofe R. Non Hodkin's lymphoma, rheumatoid arthritis and methotrexate. J Rheumatol 1993; 20: 200 – 2.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>200</start><end>2</end></extent></part><relatedItem type="host"><titleInfo><title>J Rheumatol</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>200</start><end>2</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit9"><titleInfo><title>Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein‐Barr virus and other features associated with immunosuppression</title></titleInfo><name type="personal"><namePart type="given">OW</namePart><namePart type="family">Kamel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">van de Rijn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DP</namePart><namePart type="family">Lebrun</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kamel OW. van de Rijn M, Lebrun DP et al. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein‐Barr virus and other features associated with immunosuppression. Hum Pathol 1994; 25: 638 – 43.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>638</start><end>43</end></extent></part><relatedItem type="host"><titleInfo><title>Hum Pathol</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>638</start><end>43</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit10"><titleInfo><title>Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate</title></titleInfo><name type="personal"><namePart type="given">MH</namePart><namePart type="family">Ellman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Hurwitz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Thomas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Kozloff</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991; 18: 1741 – 3.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>1741</start><end>3</end></extent></part><relatedItem type="host"><titleInfo><title>J Rheumatol</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>1741</start><end>3</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit11"><titleInfo><title>Association of methotrexate, rheumatoid arthritis and lymphoma: report of two cases and literature review</title></titleInfo><name type="personal"><namePart type="given">SF</namePart><namePart type="family">Kingsmore</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BD</namePart><namePart type="family">Hall</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NB</namePart><namePart type="family">Allen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kingsmore SF. Hall BD. Allen NB. et al. Association of methotrexate, rheumatoid arthritis and lymphoma: report of two cases and literature review. J Rheumatol 1992; 19: 1462 – 5.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>1462</start><end>5</end></extent></part><relatedItem type="host"><titleInfo><title>J Rheumatol</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>1462</start><end>5</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit12"><titleInfo><title>Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Taillan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Garnier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Castanet</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Taillan B. Garnier G. Castanet J. et al. Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate. Clin Rheumatol 1993; 12: 93 – 4.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>93</start><end>4</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Rheumatol</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>93</start><end>4</end></extent></part></relatedItem></relatedItem><identifier type="istex">BEE4962ABED858B5E2F9093D925804377F78D4E9</identifier><identifier type="ark">ark:/67375/WNG-1ZZMB2RV-C</identifier><identifier type="DOI">10.1046/j.1365-2133.1996.d01-946.x</identifier><identifier type="ArticleID">BJD116</identifier><accessCondition type="use and reproduction" contentType="copyright">© Wiley. All rights reserved.</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-13</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-1ZZMB2RV-C/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002281 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002281 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:BEE4962ABED858B5E2F9093D925804377F78D4E9
|texte= Reversible cutaneous lymphoma occurring during methotrexate therapy
}}
| This area was generated with Dilib version V0.6.33. |  |